1. Blunted cyclic variation of heart rate predicts mortality risk in post-myocardial infarction, end-stage renal disease, and chronic heart failure patients.
- Author
-
Hayano J, Yasuma F, Watanabe E, Carney RM, Stein PK, Blumenthal JA, Arsenos P, Gatzoulis KA, Takahashi H, Ishii H, Kiyono K, Yamamoto Y, Yoshida Y, Yuda E, and Kodama I
- Subjects
- Adrenergic beta-Antagonists therapeutic use, Aged, Algorithms, Chronic Disease, Electrocardiography, Ambulatory, Female, Greece, Heart Failure diagnosis, Heart Failure therapy, Humans, Japan, Kaplan-Meier Estimate, Kidney Failure, Chronic diagnosis, Kidney Failure, Chronic therapy, Male, Middle Aged, Myocardial Infarction diagnosis, Myocardial Infarction therapy, Predictive Value of Tests, Prognosis, Proportional Hazards Models, Prospective Studies, Renal Dialysis, Reproducibility of Results, Risk Factors, Signal Processing, Computer-Assisted, Stroke Volume, Time Factors, Ventricular Function, Left, Circadian Rhythm, Heart Failure mortality, Heart Failure physiopathology, Heart Rate, Kidney Failure, Chronic mortality, Kidney Failure, Chronic physiopathology, Myocardial Infarction mortality, Myocardial Infarction physiopathology
- Abstract
Aims: Cyclic variation of heart rate (CVHR) associated with sleep-disordered breathing is thought to reflect cardiac autonomic responses to apnoeic/hypoxic stress. We examined whether blunted CVHR observed in ambulatory ECG could predict the mortality risk., Methods and Results: CVHR in night-time Holter ECG was detected by an automated algorithm, and the prognostic relationships of the frequency (FCV) and amplitude (ACV) of CVHR were examined in 717 patients after myocardial infarction (post-MI 1, 6% mortality, median follow-up 25 months). The predictive power was prospectively validated in three independent cohorts: a second group of 220 post-MI patients (post-MI 2, 25.5% mortality, follow-up 45 months); 299 patients with end-stage renal disease on chronic haemodialysis (ESRD, 28.1% mortality, follow-up 85 months); and 100 patients with chronic heart failure (CHF, 35% mortality, follow-up 38 months). Although CVHR was observed in ≥96% of the patients in all cohorts, FCV did not predict mortality in any cohort. In contrast, decreased ACV was a powerful predictor of mortality in the post-MI 1 cohort (hazard ratio [95% CI] per 1 ln [ms] decrement, 2.9 [2.2-3.7], P < 0.001). This prognostic relationship was validated in the post-MI 2 (1.8 [1.4-2.2], P < 0.001), ESRD (1.5 [1.3-1.8], P < 0.001), and CHF (1.4 [1.1-1.8], P = 0.02) cohorts. The prognostic value of ACV was independent of age, gender, diabetes, β-blocker therapy, left ventricular ejection fraction, sleep-time mean R-R interval, and FCV., Conclusion: Blunted CVHR detected by decreased ACV in a night-time Holter ECG predicts increased mortality risk in post-MI, ESRD, and CHF patients., (© The Author 2016. Published by Oxford University Press on behalf of the European Society of Cardiology.)
- Published
- 2017
- Full Text
- View/download PDF